GOLPH3通过JNK信号通路抑制质瘤细胞亡
Shao Xie1,2, Jiahai Ding2, Zhaohao Wang3
1Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Frontiers in genetics
|February 13, 2025
概括
高尔基脂蛋白3 (GOLPH3) 倒退通过JNK通路增加了质瘤细胞的亡. 抑制GOLPH3抑制瘤生长,为质瘤治疗提供了潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 质瘤是一种主要的内瘤,具有显著的死亡率和残疾挑战.
- 了解质瘤的分子机制和确定治疗点对于改善患者的治疗结果至关重要.
- 高尔基蛋白3 (GOLPH3) 涉及各种癌症,但其在质瘤进展中的作用需要进一步调查.
研究的目的:
- 为了阐明戈尔吉蛋白3 (GOLPH3) 在质瘤进展中的作用.
- 研究GOLPH3在调节细胞亡和JNK信号通路中的作用.
- 评估GOLPH3作为质瘤基因治疗的潜在治疗点.
主要方法:
- 使用小干扰RNA (siRNA) 在U87质瘤细胞中抑制了GOLPH3表达.
- 通过将GOLPH3-knockdown U87细胞植入裸体小鼠中,建立了一个体内质瘤模型.
- 通过流细胞计,免疫光,TUNEL试验和西部抹迹来评估亡;通过分析JNK和c-Jun酸化来评估JNK通路激活.
主要成果:
- 降低GOLPH3的调节显著增强了U87质瘤细胞的亡,由分裂的caspase-3和更高的亡率的增加表明.
- GOLPH3的淘汰激活了JNK信号通路,由JNK和c-Jun的高酸化证明.
- 在体内,GOLPH3抑制抑制了瘤生长,并在瘤微环境中增加了亡.
结论:
- GOLPH3在调节恶性质瘤细胞的亡中发挥着关键作用,可能通过JNK信号通路.
- GOLPH3 代表了一种有前途的治疗质瘤治疗标.
- 对GOLPH3机制的进一步研究可能会导致针对质瘤的新型基因治疗策略.
更多相关视频
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
The Intrinsic Apoptotic Pathway
6.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


